Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,000
Closed -$95K – 7078
2019
Q1
$95K Sell
1,000
-10,000
-91% -$1.25M ﹤0.01% 5397
2018
Q4
$1.37M Buy
+11,000
New +$1.81M ﹤0.01% 2797

Other funds holding INGN

Barclays's INGN Position: Q3 2026 in Review

Barclays increased its Inogen (INGN) stake by 13% in Q3 2026, buying an estimated $33.7K and bringing the position to 48,334 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Barclays first reported a position in INGN in Q1 2014 and has held it in 51 quarters since. The position peaked at $3.79M in Q4 2015. 61 funds tracked by Wall St. Rank hold INGN as of Q3 2026.

  • Barclays held 48,334 shares of Inogen worth $255K as of Q3 2026.
  • Barclays bought 5,727 Inogen shares in Q3 2026, an estimated $33.7K.
  • Inogen made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3826 holding.
  • Barclays first reported a position in Inogen in Q1 2014 and has held it in 51 quarters since.
  • Barclays's Inogen position peaked at $3.79M in Q4 2015.
  • 61 funds tracked by Wall St. Rank held Inogen as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.